OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current progress in innovative engineered antibodies
William R. Strohl
Protein & Cell (2017) Vol. 9, Iss. 1, pp. 86-120
Open Access | Times Cited: 252
William R. Strohl
Protein & Cell (2017) Vol. 9, Iss. 1, pp. 86-120
Open Access | Times Cited: 252
Showing 1-25 of 252 citing articles:
Antibody–Drug Conjugates: A Comprehensive Review
Puregmaa Khongorzul, Cai Ling, Farhan Ullah Khan, et al.
Molecular Cancer Research (2019) Vol. 18, Iss. 1, pp. 3-19
Closed Access | Times Cited: 620
Puregmaa Khongorzul, Cai Ling, Farhan Ullah Khan, et al.
Molecular Cancer Research (2019) Vol. 18, Iss. 1, pp. 3-19
Closed Access | Times Cited: 620
Antibody Structure and Function: The Basis for Engineering Therapeutics
Mark L. Chiu, Dennis R. Goulet, A. Teplyakov, et al.
Antibodies (2019) Vol. 8, Iss. 4, pp. 55-55
Open Access | Times Cited: 482
Mark L. Chiu, Dennis R. Goulet, A. Teplyakov, et al.
Antibodies (2019) Vol. 8, Iss. 4, pp. 55-55
Open Access | Times Cited: 482
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
Peter Bannas, Julia Hambach, Friedrich Koch‐Nolte
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 468
Peter Bannas, Julia Hambach, Friedrich Koch‐Nolte
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 468
IgG Fc engineering to modulate antibody effector functions
Xinhua Wang, Mary Mathieu, Randall J. Brezski
Protein & Cell (2017) Vol. 9, Iss. 1, pp. 63-73
Open Access | Times Cited: 295
Xinhua Wang, Mary Mathieu, Randall J. Brezski
Protein & Cell (2017) Vol. 9, Iss. 1, pp. 63-73
Open Access | Times Cited: 295
The pharmacology and therapeutic applications of monoclonal antibodies
Sofia Castelli, Paul McGonigle, Pamela J. Hornby
Pharmacology Research & Perspectives (2019) Vol. 7, Iss. 6
Open Access | Times Cited: 253
Sofia Castelli, Paul McGonigle, Pamela J. Hornby
Pharmacology Research & Perspectives (2019) Vol. 7, Iss. 6
Open Access | Times Cited: 253
Structure, heterogeneity and developability assessment of therapeutic antibodies
Yingda Xu, Dongdong Wang, Bruce D. Mason, et al.
mAbs (2018) Vol. 11, Iss. 2, pp. 239-264
Open Access | Times Cited: 227
Yingda Xu, Dongdong Wang, Bruce D. Mason, et al.
mAbs (2018) Vol. 11, Iss. 2, pp. 239-264
Open Access | Times Cited: 227
Considerations for the Design of Antibody-Based Therapeutics
Dennis R. Goulet, William M. Atkins
Journal of Pharmaceutical Sciences (2019) Vol. 109, Iss. 1, pp. 74-103
Open Access | Times Cited: 219
Dennis R. Goulet, William M. Atkins
Journal of Pharmaceutical Sciences (2019) Vol. 109, Iss. 1, pp. 74-103
Open Access | Times Cited: 219
Targeted Intracellular Delivery of Antibodies: The State of the Art
Tatiana A. Slastnikova, A. V. Ulasov, Andrey A. Rosenkranz, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 179
Tatiana A. Slastnikova, A. V. Ulasov, Andrey A. Rosenkranz, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 179
Biological drug and drug delivery-mediated immunotherapy
Qingqing Xiao, Xiaotong Li, Yi Li, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 4, pp. 941-960
Open Access | Times Cited: 156
Qingqing Xiao, Xiaotong Li, Yi Li, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 4, pp. 941-960
Open Access | Times Cited: 156
The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Linghui Qian, Xuefen Lin, Xue Gao, et al.
Chemical Reviews (2023) Vol. 123, Iss. 12, pp. 7782-7853
Closed Access | Times Cited: 66
Linghui Qian, Xuefen Lin, Xue Gao, et al.
Chemical Reviews (2023) Vol. 123, Iss. 12, pp. 7782-7853
Closed Access | Times Cited: 66
The Evolving Landscape of Antibody–Drug Conjugates: In Depth Analysis of Recent Research Progress
Janet M. Sasso, Rumiana Tenchov, Robert E. Bird, et al.
Bioconjugate Chemistry (2023) Vol. 34, Iss. 11, pp. 1951-2000
Open Access | Times Cited: 55
Janet M. Sasso, Rumiana Tenchov, Robert E. Bird, et al.
Bioconjugate Chemistry (2023) Vol. 34, Iss. 11, pp. 1951-2000
Open Access | Times Cited: 55
Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)
Ricarda M. Hoffmann, Ben G T Coumbe, Debra H. Josephs, et al.
OncoImmunology (2017) Vol. 7, Iss. 3, pp. e1395127-e1395127
Open Access | Times Cited: 145
Ricarda M. Hoffmann, Ben G T Coumbe, Debra H. Josephs, et al.
OncoImmunology (2017) Vol. 7, Iss. 3, pp. e1395127-e1395127
Open Access | Times Cited: 145
Targeting PVR (CD155) and its receptors in anti-tumor therapy
Paola Kučan Brlić, T. Rovis, Guy Cinamon, et al.
Cellular and Molecular Immunology (2018) Vol. 16, Iss. 1, pp. 40-52
Open Access | Times Cited: 144
Paola Kučan Brlić, T. Rovis, Guy Cinamon, et al.
Cellular and Molecular Immunology (2018) Vol. 16, Iss. 1, pp. 40-52
Open Access | Times Cited: 144
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy
Juan C. Almagro, Tracy R. Daniels‐Wells, Sonia Mayra Pérez‐Tapia, et al.
Frontiers in Immunology (2018) Vol. 8
Open Access | Times Cited: 136
Juan C. Almagro, Tracy R. Daniels‐Wells, Sonia Mayra Pérez‐Tapia, et al.
Frontiers in Immunology (2018) Vol. 8
Open Access | Times Cited: 136
Therapeutic Fc‐fusion proteins: Current analytical strategies
Bastiaan L. Duivelshof, Amarande Murisier, Julien Camperi, et al.
Journal of Separation Science (2020) Vol. 44, Iss. 1, pp. 35-62
Open Access | Times Cited: 116
Bastiaan L. Duivelshof, Amarande Murisier, Julien Camperi, et al.
Journal of Separation Science (2020) Vol. 44, Iss. 1, pp. 35-62
Open Access | Times Cited: 116
Antibody Fragment and Affibody ImmunoPET Imaging Agents: Radiolabelling Strategies and Applications
Ruisi Fu, Laurence Carroll, Gökhan Yahioglu, et al.
ChemMedChem (2018) Vol. 13, Iss. 23, pp. 2466-2478
Open Access | Times Cited: 96
Ruisi Fu, Laurence Carroll, Gökhan Yahioglu, et al.
ChemMedChem (2018) Vol. 13, Iss. 23, pp. 2466-2478
Open Access | Times Cited: 96
Development of Comprehensive Online Two-Dimensional Liquid Chromatography/Mass Spectrometry Using Hydrophilic Interaction and Reversed-Phase Separations for Rapid and Deep Profiling of Therapeutic Antibodies
Dwight R. Stoll, David C. Harmes, Gregory O. Staples, et al.
Analytical Chemistry (2018) Vol. 90, Iss. 9, pp. 5923-5929
Closed Access | Times Cited: 91
Dwight R. Stoll, David C. Harmes, Gregory O. Staples, et al.
Analytical Chemistry (2018) Vol. 90, Iss. 9, pp. 5923-5929
Closed Access | Times Cited: 91
Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites
Roos M. de Jong, Surafel K. Tebeje, Lisette Meerstein‐Kessel, et al.
Immunological Reviews (2019) Vol. 293, Iss. 1, pp. 190-215
Open Access | Times Cited: 82
Roos M. de Jong, Surafel K. Tebeje, Lisette Meerstein‐Kessel, et al.
Immunological Reviews (2019) Vol. 293, Iss. 1, pp. 190-215
Open Access | Times Cited: 82
Ionic Liquids and Deep Eutectic Solvents for Enhanced Delivery of Antibodies in the Gastrointestinal Tract
Pavimol Angsantikul, Kevin Peng, Alexander M. Curreri, et al.
Advanced Functional Materials (2020) Vol. 31, Iss. 44
Closed Access | Times Cited: 77
Pavimol Angsantikul, Kevin Peng, Alexander M. Curreri, et al.
Advanced Functional Materials (2020) Vol. 31, Iss. 44
Closed Access | Times Cited: 77
Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance
Arthur Géraud, Paul Gougis, Aurore Vozy, et al.
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 85-112
Open Access | Times Cited: 75
Arthur Géraud, Paul Gougis, Aurore Vozy, et al.
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 85-112
Open Access | Times Cited: 75
Human antibodies neutralizing diphtheria toxin in vitro and in vivo
Esther Veronika Wenzel, Margarita Bosnak, Robert Tierney, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 72
Esther Veronika Wenzel, Margarita Bosnak, Robert Tierney, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 72
Fc-engineered antibodies with immune effector functions completely abolished
Ian Wilkinson, Stephen F. Anderson, Jeremy Fry, et al.
PLoS ONE (2021) Vol. 16, Iss. 12, pp. e0260954-e0260954
Open Access | Times Cited: 62
Ian Wilkinson, Stephen F. Anderson, Jeremy Fry, et al.
PLoS ONE (2021) Vol. 16, Iss. 12, pp. e0260954-e0260954
Open Access | Times Cited: 62
Capillary electrophoresis and the biopharmaceutical industry: Therapeutic protein analysis and characterization
Harleen Kaur, Jeff Beckman, Yiting Zhang, et al.
TrAC Trends in Analytical Chemistry (2021) Vol. 144, pp. 116407-116407
Open Access | Times Cited: 60
Harleen Kaur, Jeff Beckman, Yiting Zhang, et al.
TrAC Trends in Analytical Chemistry (2021) Vol. 144, pp. 116407-116407
Open Access | Times Cited: 60
Evolution of phage display libraries for therapeutic antibody discovery
Yang Zhang
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 37
Yang Zhang
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 37
Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
Kyle P. Martin, Christine Grimaldi, Rolf Grempler, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 36
Kyle P. Martin, Christine Grimaldi, Rolf Grempler, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 36
